Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10024711HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10030012HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10021733HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10030013HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10030014HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10024504HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10030015HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10020955HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10030016HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TVIS10034949HBVENSG00000164362.21protein_codingTERTYesNo7015O14746
TCGA Plot Options
Drug Information
GeneTERT
DrugBank IDDB12747
Drug NameTertomotide
Target IDBE0002449
UniProt IDO14746
Regulation Type
PubMed IDs17258078
CitationsKokhaei P, Palma M, Hansson L, Osterborg A, Mellstedt H, Choudhury A: Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells. Exp Hematol. 2007 Feb;35(2):297-304.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL